Oral cancer remains a serious global health concern due to its high morbidity and mortality rates, primarily caused by late-stage diagnosis.
FDA clinical trial inclusivity guidelines will be back
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the FDA’s Diversity Action Plan guidelines — requiring pharmaceutical companies to test drugs
February 6, 2025